Developer docs
API playgroundTry for free, no card

Search company profiles

Qdossier

Full company profile

uuid0027ubn

Namestring
Qdossier
Websiteurl
qdossier.com
Company typeenum
Private
Founded yearint
2006
Short descriptiontext

Qdossier is a private Netherlands-based pharmaceutical regulatory documentation specialist, founded in 2006 and headquartered in Waalwijk, that focuses on the efficient recording and exchange of proof of quality, safety, and efficacy of medicinal products for drug manufacturers and regulators.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWaalwijk, Netherlands
HQ citystring
Waalwijk
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pharmaceutical regulatory dossiers, drug safety documentation, medicinal product registration, quality safety efficacy records, regulatory document exchange
Industry3 codes
PRIMARYHLAIAKAC
Value Dossier & Evidence Generation (AMCP/Global Value Dossier)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAGAKAD
Quality Management Systems (QMS) & GxP Documentation
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAH
Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
Product category
Pharmaceutical Regulatory Documentation
No data
Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Qdossier provides a service focused on the efficient recording and exchange of documentation proving the quality, safety, and efficacy of medicinal products. The offering is aimed at pharmaceutical regulatory workflows where sponsors, manufacturers, and regulators must compile and share structured product dossiers.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Qdossier dossier recording and exchange service
CategoryPharmaceutical Regulatory Documentation
Description

A service that enables the recording and exchange of documentation proving the quality, safety, and efficacy of medicinal products, intended for pharmaceutical sponsors, manufacturers, and regulatory affairs teams managing regulatory dossiers.

No data
Peers10 records
TypeBroad incumbent
Description

Parexel is a global CRO offering regulatory consulting, dossier authoring, and submission services. It overlaps with Qdossier's regulatory documentation work and is the type of scaled competitor that may pressure niche dossier specialists.

TypeDirect peer
Description

Veeva's Vault RIM platform manages regulatory information, submissions, and dossiers for life sciences customers. It directly overlaps with Qdossier's focus on recording and exchange of quality, safety, and efficacy documentation for medicinal products.

TypeDirect peer
Description

PharmaLex (now part of Cencora) provides regulatory affairs consulting and dossier services to pharma companies. It serves the same customer need as Qdossier - compiling and managing quality/safety/efficacy submissions.

TypeBroad incumbent
Description

IQVIA is a large CRO and life sciences services firm whose regulatory affairs practice includes dossier preparation, submission management, and pharmacovigilance documentation. It competes with Qdossier across the regulatory documentation workflow as part of a much broader portfolio.

TypeDirect peer
Description

ArisGlobal provides life sciences regulatory, safety, and pharmacovigilance software, including solutions for document management and dossier submissions. Its regulatory information management product competes in the same workflow Qdossier addresses.

TypeDirect peer
Description

Arriello provides regulatory affairs, compliance, and pharmacovigilance services for life sciences, including documentation and dossier support. It is a similarly-sized European specialist that competes for the same kinds of mid-market biopharma engagements as Qdossier.

TypeDirect peer
Description

Generis provides the CARA regulatory information management platform used by pharma for dossier, submission, and product registration management. It competes head-on with Qdossier's recording and exchange value proposition.

TypeDirect peer
Description

LORENZ offers the docuBridge suite for electronic regulatory submissions and dossier publishing. It serves the same eCTD/dossier exchange workflow that Qdossier supports for pharmaceutical sponsors.

TypeBroad incumbent
Description

ICON provides regulatory and clinical services to pharma, including submission and dossier support functions. As a global CRO with broad capabilities, it represents an incumbent option for clients who might otherwise engage a niche dossier specialist like Qdossier.

TypeBroad incumbent
Description

DXC Technology (via the former CSC Life Sciences unit) provides regulatory information management and submission software to pharma. Its broader IT services portfolio positions it as an incumbent alternative to smaller dossier specialists like Qdossier.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qdossier

Pharmaceutical Regulatory Documentationqdossier.com

Qdossier is a private Netherlands-based pharmaceutical regulatory documentation specialist, founded in 2006 and headquartered in Waalwijk, that focuses on the efficient recording and exchange of proof of quality, safety, and efficacy of medicinal products for drug manufacturers and regulators.

Qdossier firmographics

Firmographics
Name
Qdossier
Website
https://qdossier.com
Company type
Private
Founded year
2006
Headcount range
1–10 employees
Short description
Qdossier is a private Netherlands-based pharmaceutical regulatory documentation specialist, founded in 2006 and headquartered in Waalwijk, that focuses on the efficient recording and exchange of proof of quality, safety, and efficacy of medicinal products for drug manufacturers and regulators.
Ownership category
akta.pro rank

Qdossier industry classification

Industry
Product category
Pharmaceutical Regulatory Documentation
akta.pro industry
PRIMARYHLAIAKAC
Value Dossier & Evidence Generation (AMCP/Global Value Dossier)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAGAKAD
Quality Management Systems (QMS) & GxP Documentation
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAH
Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Pharmaceutical regulatory dossiers
  • Drug safety documentation
  • Medicinal product registration
  • Quality safety efficacy records
  • Regulatory document exchange

Where Qdossier is headquartered

Location

Headquarters

HQ city
Waalwijk
HQ country
Netherlands
HQ region
Europe

Markets served

Qdossier business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Qdossier product offering

Product offering

Core offering

Qdossier provides a service focused on the efficient recording and exchange of documentation proving the quality, safety, and efficacy of medicinal products. The offering is aimed at pharmaceutical regulatory workflows where sponsors, manufacturers, and regulators must compile and share structured product dossiers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Qdossier dossier recording and exchange service A service that enables the recording and exchange of documentation proving the quality, safety, and efficacy of medicinal products, intended for pharmaceutical sponsors, manufacturers, and regulatory affairs teams managing regulatory dossiers.

Companies that use Qdossier

Customer profile

Ideal customer profiles1 record

Qdossier technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Qdossier competitors and assessment

Company assessment

Broad incumbents

  • Parexel International: Parexel is a global CRO offering regulatory consulting, dossier authoring, and submission services. It overlaps with Qdossier's regulatory documentation work and is the type of scaled competitor that may pressure niche dossier specialists.
  • IQVIA: IQVIA is a large CRO and life sciences services firm whose regulatory affairs practice includes dossier preparation, submission management, and pharmacovigilance documentation. It competes with Qdossier across the regulatory documentation workflow as part of a much broader portfolio.
  • ICON plc (PRA Health / DOCS): ICON provides regulatory and clinical services to pharma, including submission and dossier support functions. As a global CRO with broad capabilities, it represents an incumbent option for clients who might otherwise engage a niche dossier specialist like Qdossier.
  • DXC Technology (CSC Life Sciences): DXC Technology (via the former CSC Life Sciences unit) provides regulatory information management and submission software to pharma. Its broader IT services portfolio positions it as an incumbent alternative to smaller dossier specialists like Qdossier.

Direct peers

  • Veeva Systems: Veeva's Vault RIM platform manages regulatory information, submissions, and dossiers for life sciences customers. It directly overlaps with Qdossier's focus on recording and exchange of quality, safety, and efficacy documentation for medicinal products.
  • PharmaLex: PharmaLex (now part of Cencora) provides regulatory affairs consulting and dossier services to pharma companies. It serves the same customer need as Qdossier - compiling and managing quality/safety/efficacy submissions.
  • ArisGlobal: ArisGlobal provides life sciences regulatory, safety, and pharmacovigilance software, including solutions for document management and dossier submissions. Its regulatory information management product competes in the same workflow Qdossier addresses.
  • Arriello: Arriello provides regulatory affairs, compliance, and pharmacovigilance services for life sciences, including documentation and dossier support. It is a similarly-sized European specialist that competes for the same kinds of mid-market biopharma engagements as Qdossier.
  • Generis (RIM/Regulatory Data Management): Generis provides the CARA regulatory information management platform used by pharma for dossier, submission, and product registration management. It competes head-on with Qdossier's recording and exchange value proposition.
  • LORENZ Life Sciences: LORENZ offers the docuBridge suite for electronic regulatory submissions and dossier publishing. It serves the same eCTD/dossier exchange workflow that Qdossier supports for pharmaceutical sponsors.

Market position

Customer concentration

Qdossier financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qdossier leadership team

Management profile

Number of profiles

Qdossier funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qdossier M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qdossier

What does Qdossier do?

Qdossier provides a service focused on the efficient recording and exchange of documentation proving the quality, safety, and efficacy of medicinal products. The offering is aimed at pharmaceutical regulatory workflows where sponsors, manufacturers, and regulators must compile and share structured product dossiers.

When was Qdossier founded?

Qdossier was founded in 2006. It employs 1 to 10 people.

Where is Qdossier based?

Qdossier is headquartered in Waalwijk, Netherlands, in the Europe region.

Who are Qdossier's main competitors?

Broad incumbents on record are Parexel International, IQVIA, ICON plc (PRA Health / DOCS) and DXC Technology (CSC Life Sciences). Direct peers are Veeva Systems, PharmaLex, ArisGlobal, Arriello, Generis (RIM/Regulatory Data Management) and LORENZ Life Sciences.

Does Qdossier have an API?

No public API is recorded for Qdossier.

What industry is Qdossier in?

Qdossier's product category is Pharmaceutical Regulatory Documentation. Its primary akta.pro industry code is HLAIAKAC, Value Dossier & Evidence Generation (AMCP/Global Value Dossier), with a secondary code of HLAGAKAD, Quality Management Systems (QMS) & GxP Documentation.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFiling eCTD (electronic Common Technical Document) Submissions Training Course: Now Mandatory for Submissions in the EU and Global regulatory AgenciesResearchAndMarkets.com has added a one-day training course on eCTD submissions to its portfolio, aimed at regulatory professionals in the pharmaceutical industry. The course covers implementation of efficient processes for submitting electronic dossiers to regulatory agencies in the EU and US. Speakers from Qdossier, a Celegence company, will share practical experiences and validation criteria.CelegenceRegulatory Consultancy ServicesCelegence has acquired Qdossier to enhance its regulatory consultancy services for the life sciences and pharmaceutical industries. This acquisition aims to improve efficiency in regulatory compliance and support the successful launch and maintenance of products in the market. The combination of expertise and technology from both companies aims to deliver strategic regulatory support globally.PR NewswireCelegence acquires Qdossier to bolster its regulatory consultancy services and solutions for the pharmaceutical industryCelegence announced the acquisition of Qdossier to enhance its regulatory consultancy services and cloud-based technology offerings for the pharmaceutical industry. The combination brings Qdossier's Dossplorer solution and regulatory experts into Celegence's portfolio, increasing their combined workforce to 150 employees across offices in Chicago, London, Bangalore, the Netherlands, and Romania.